The effect of granulocyte colony stimulating factor in patients with leukopenia due to sepsis.

The use of granulocyte stimulating factor (G-CSF) (Neupogen, Amgen Inc., Thousand Oaks, Calif.) has become acceptable for treating both primary and acquired leukopenia.